Acurx Pharmaceuticals, Inc. SEC filings ACXP
Acurx Pharmaceuticals, Inc. has 245 filings in SEC EDGAR's recent list, going back to Apr 3, 2018. Its latest annual report, Form ARS, was filed on Sep 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 16, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 22, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 19, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 17, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 20, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 28, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 10, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 26, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 7, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 15, 2023 | Nov 15, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Nov 3, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Oct 2, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 20, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
May 17, 2023 | May 16, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Jul 25, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 16, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 29, 2021 | Jun 23, 2021 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACXP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Staten Island, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1736243
- Former names
- Acurx Pharmaceuticals, LLC (until Jun 23, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.